Autori: Chandra Deepa
| Naslov | Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate (Article) |
| Autori | Robinson Michael F Damjanov Nemanja S Stamenkovic Bojana N  Radunovic Goran L Kivitz Alan J Cox Lori Manukyan Zorayr Banfield Christopher Saunders Michael Chandra Deepa Vincent Michael S Mancuso Jessica Peeva Elena Beebe Jean S
|
| Info | ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. 10, str. 1621-1631 |
| Projekat | Pfizer, Inc.Pfizer |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate (Article) |
| Autori | Robinson Michael F Damjanov Nemanja S Stamenkovic Bojana N Radunovic Goran L Kivitz Alan J Cox Lori Manukyan Zorayr Banfield Christopher Saunders Michael Chandra Deepa Vincent Michael S Mancuso Jessica Peeva Elena Beebe Jean S
|
| Info | ARTHRITIS & RHEUMATOLOGY, (2020), vol. 72 br. 10, str. 1621-1631 |
| Projekat | Pfizer, Inc.Pfizer |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
